Since TMPRSS2 is an androgen-dependent gene, the fusion protein encoded by TMPRSS2/ERG is overexpressed in prostate cancer, which contributes to tumor progression [35]. This evidence concerns the gene TMPRSS2 and prostate carcinoma.